{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:49:51Z","timestamp":1792586991950,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Administration of Traditional Chinese Medicine High Level Key Discipline Construction Project for Traditional Chinese Medicine \u2013 Ethnic Minority Pharmacy","award":["zyyzdxk 2023165"],"award-info":[{"award-number":["zyyzdxk 2023165"]}]},{"name":"National Administration of Traditional Chinese Medicine National Veteran Pharmacist Inheritance Studio Construction Project","award":["State TCM Personnel Education Letter [2024] No. 255"],"award-info":[{"award-number":["State TCM Personnel Education Letter [2024] No. 255"]}]},{"name":"Guangxi Zhuang Autonomous Region Administration of Traditional Chinese Medicine Self Funded Scientific Research Project","award":["GXZYA20220171"],"award-info":[{"award-number":["GXZYA20220171"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"DOI":"10.1007\/s12033-026-01608-8","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:37:42Z","timestamp":1792586262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Potential Mechanism of Ethyl Acetate Extract from\u00a0Tumor Vine\u00a0in Combination with Cisplatin for Treating Non-Small Cell Lung Cancer Based on Network Pharmacology and Cellular Experiments"],"prefix":"10.1007","author":[{"given":"Leimin","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3500-8162","authenticated-orcid":false,"given":"Jiangcun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"1608_CR1","doi-asserted-by":"publisher","first-page":"1554871","DOI":"10.3389\/fimmu.2025.1554871","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang, J., Song, Z., Zhang, Y., Wang, T., Li, Q., Chen, X., et al. (2025). Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer. Frontiers in Immunology, 16, 1554871.","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"1608_CR2","doi-asserted-by":"publisher","first-page":"119884","DOI":"10.1016\/j.bbamcr.2024.119884","volume":"1872","author":"CY Huang","year":"2025","unstructured":"Huang, C. Y., Chen, L. J., Chen, G., Liu, W., Yang, J., Wu, H., et al. (2025). Enhanced radiotherapy susceptibility in NSCLC through palbociclib-mediated PP5 inhibition. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1872(2), 119884.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"issue":"4","key":"1608_CR3","first-page":"87","volume":"43","author":"XQ Dang","year":"2025","unstructured":"Dang, X. Q., Chen, P., & Zhong, S. (2025). A clinical evaluation study on the treatment of non-small cell lung cancer based on the \u201ccombination of cold, hot, warm, and cool\u201d method in the real world. Journal of Sichuan Traditional Chinese Medicine, 43(4), 87\u201390.","journal-title":"Journal of Sichuan Traditional Chinese Medicine"},{"issue":"Pt 2","key":"1608_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.semcancer.2022.06.010","volume":"86","author":"S Srivastava","year":"2022","unstructured":"Srivastava, S., Mohanty, A., Nam, A., Singh, R., Chakraborty, S., Kumar, A., et al. (2022). Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics. Seminars in Cancer Biology, 86(Pt 2), 233\u2013246.","journal-title":"Seminars in Cancer Biology"},{"issue":"2","key":"1608_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21037\/cco-23-92","volume":"13","author":"T Wang","year":"2024","unstructured":"Wang, T., Zhang, L., & Cheng, Y. (2024). Clinical status and perspective on the application of immunotherapy combined with chemotherapy in advanced non-small cell lung cancer: A review. Chinese Clinical Oncology, 13(2), 26.","journal-title":"Chinese Clinical Oncology"},{"key":"1608_CR6","unstructured":"Sun, C. Y. (2019). Study on the sensitization effect of scutellarin to cisplatin against non-small cell lung cancer and its protective effect on cisplatin-induced nephrotoxicity [Master\u2019s thesis]. Guangzhou University of Chinese Medicine."},{"issue":"2","key":"1608_CR7","first-page":"215","volume":"42","author":"JW Huang","year":"2025","unstructured":"Huang, J. W., Feng, Z. Y., Wang, K. Y., Li, M., Zhang, L., Chen, Y., et al. (2025). Exploring the potential mechanism of Guilu Erxian Glue in combination with cisplatin for treating non-small cell lung cancer based on network pharmacology and animal experiments. Chinese Journal of Modern Applied Pharmacy, 42(2), 215\u2013225.","journal-title":"Chinese Journal of Modern Applied Pharmacy"},{"key":"1608_CR8","unstructured":"Editorial Committee of Beijing Institute of Botany, Chinese Academy of Sciences (Ed.). (1972). Iconographia Cormophytorum Sinicorum, Tomus II [M]. Beijing: Science Press."},{"issue":"20","key":"1608_CR9","first-page":"6862","volume":"55","author":"GS Lu","year":"2024","unstructured":"Lu, G. S., Hu, X. X., Huang, Z. F., Wang, L., Li, P., Chen, Q., et al. (2024). Rapid discovery of chemical constituents in the rare allied plant Pileostegia tomentella based on biosynthesis pathway combined with LC-MS technique. Chinese Traditional and Herbal Drugs, 55(20), 6862\u20136873.","journal-title":"Chinese Traditional and Herbal Drugs"},{"issue":"10","key":"1608_CR10","first-page":"1767","volume":"32","author":"HS Zhou","year":"2024","unstructured":"Zhou, H. S., Li, Y. P., Jin, M. J., Zhang, W., Liu, X., Wu, Z., et al. (2024). Xiaoliuteng ethyl acetate extraction\u2019s impact on proliferation, apoptosis, and the Bax\/Bcl-2\/Caspase-3 signaling pathway in human colorectal cancer cells. Journal of Modern Oncology, 32(10), 1767\u20131773.","journal-title":"Journal of Modern Oncology"},{"issue":"2","key":"1608_CR11","first-page":"73","volume":"50","author":"YQ Shi","year":"2022","unstructured":"Shi, Y. Q., Geng, M. L., Li, H. N., Wang, F., Zhang, Y., Chen, J., et al. (2022). Study on the ethyl acetate fraction of Pileostegia tomentella against triple-negative breast cancer. Guangzhou Chemical Industry, 50(2), 73\u201376.","journal-title":"Guangzhou Chemical Industry"},{"key":"1608_CR12","first-page":"e123456","volume":"223","author":"W Zhong","year":"2025","unstructured":"Zhong, W., Jiang, L., Qing, B., Liu, Y., Wang, H., Li, Q., et al. (2025). Anticancer effects of key constituents of Pileostegia tomentella via ROS-mediated classical apoptosis in non-small cell lung cancer cells. Journal of Visualized Experiments, 223, e123456.","journal-title":"Journal of Visualized Experiments"},{"key":"1608_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/bs.acc.2023.02.004","volume":"114","author":"XD Ren","year":"2023","unstructured":"Ren, X. D., Su, N., Sun, X. G., Zhang, Y., Huang, J., Liu, T., et al. (2023). Advances in liquid biopsy-based markers in NSCLC. Advances in Clinical Chemistry, 114, 109\u2013150.","journal-title":"Advances in Clinical Chemistry"},{"issue":"21","key":"1608_CR14","first-page":"60","volume":"14","author":"LQ Kang","year":"2021","unstructured":"Kang, L. Q., Luo, C., & Zhang, M. Z. (2021). Clinical efficacy of anlotinib combined with AP chemotherapy in the treatment of advanced non-small cell lung cancer. Chinese Journal of Clinical Rational Drug Use, 14(21), 60\u201363.","journal-title":"Chinese Journal of Clinical Rational Drug Use"},{"key":"1608_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.lungcan.2019.08.001","volume":"136","author":"W Tang","year":"2019","unstructured":"Tang, W., Li, X., Xie, X., Chen, Y., Zhang, H., Wang, M., et al. (2019). EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations. Lung Cancer, 136, 6\u201314.","journal-title":"Lung Cancer"},{"issue":"4","key":"1608_CR16","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s12094-024-03731-x","volume":"27","author":"G Gomatou","year":"2025","unstructured":"Gomatou, G., Charpidou, A., Li, P., Wang, Y., Chen, Q., Zhang, L., et al. (2025). Mechanisms of primary resistance to immune checkpoint inhibitors in NSCLC. Clinical and Translational Oncology, 27(4), 1426\u20131437.","journal-title":"Clinical and Translational Oncology"},{"key":"1608_CR17","doi-asserted-by":"publisher","first-page":"963689721104158","DOI":"10.1177\/09636897211041587","volume":"30","author":"J Chen","year":"2021","unstructured":"Chen, J., Alduais, Y., & Chen, B. (2021). Therapeutic and systemic adverse events of immune checkpoint inhibitors targeting the PD-1\/PD-L1 axis for clinical management of NSCLC. Cell Transplantation, 30, 9636897211041588.","journal-title":"Cell Transplantation"},{"key":"1608_CR18","unstructured":"Zhang, S. R., Zhang, Y., Ou, Y., Li, M., Wang, X., & Chen, H. et al. (2025). Survival analysis and cohort study of eliminating turbidity and cultivating foundation method combined with platinum-based chemotherapy as first-line treatment for extensive-stage small cell lung cancer. Liaoning Journal of Traditional Chinese Medicine, 1\u201325."},{"issue":"6","key":"1608_CR19","first-page":"707","volume":"41","author":"WC Yuan","year":"2025","unstructured":"Yuan, W. C., Zhou, H. G., Li, W. T., Liu, J., Yang, B., Chen, S., et al. (2025). Current status, advantages, and strategies of traditional Chinese medicine in the prevention and treatment of malignant tumors. Journal of Nanjing University of Traditional Chinese Medicine, 41(6), 707\u2013720.","journal-title":"Journal of Nanjing University of Traditional Chinese Medicine"},{"issue":"5","key":"1608_CR20","first-page":"246","volume":"21","author":"LM Jiang","year":"2025","unstructured":"Jiang, L. M., Wei, J. C., & Zhong, W. (2025). Research progress on Tumor Vine (Pileostegia tomentella). Asia-Pacific Traditional Medicine, 21(5), 246\u2013250.","journal-title":"Asia-Pacific Traditional Medicine"},{"issue":"6","key":"1608_CR21","first-page":"1115","volume":"39","author":"L Li","year":"2023","unstructured":"Li, L., Lu, G. S., Wang, L., Liu, Y., Zhang, H., Wu, J., et al. (2023). Total coumarins from Tumor Vine inhibit the proliferation of small cell lung cancer H1688 cells by inducing ferroptosis. Chinese Pharmacological Bulletin, 39(6), 1115\u20131121.","journal-title":"Chinese Pharmacological Bulletin"},{"issue":"2","key":"1608_CR22","first-page":"380","volume":"31","author":"L Li","year":"2024","unstructured":"Li, L., Deng, Y. Y., Lyu, J. H., Wang, X., Chen, M., Zhang, Q., et al. (2024). Study on the effect of total coumarins from Tumor Vine inducing ferroptosis in colorectal cancer cells. Guangxi Sciences, 31(2), 380\u2013388.","journal-title":"Guangxi Sciences"},{"issue":"8","key":"1608_CR23","first-page":"126","volume":"29","author":"XX Hu","year":"2023","unstructured":"Hu, X. X., Huang, J. Y., Huang, Z. F., Li, L., Wang, Y., Chen, W., et al. (2023). Exploring the mechanism of action of Tumor Vine in the treatment of uterine fibroids based on network pharmacology. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 29(8), 126\u2013131.","journal-title":"Guiding Journal of Traditional Chinese Medicine and Pharmacy"},{"issue":"6","key":"1608_CR24","first-page":"723","volume":"46","author":"ZC Jiang","year":"2025","unstructured":"Jiang, Z. C., Peng, P. C., Li, X. M., Liu, Q., Zhang, R., Chen, L., et al. (2025). Exploring the effect mechanism of Yao medicine Tumor Vine on HepG2 liver cancer cells based on the HIF-1\u03b1\/VEGF signaling pathway. Shaanxi Journal of Traditional Chinese Medicine, 46(6), 723\u2013728.","journal-title":"Shaanxi Journal of Traditional Chinese Medicine"},{"issue":"1","key":"1608_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/13880209.2024.2309871","volume":"62","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Cheng, D. H., Su, Z. Y., Li, W., Zhang, Q., Chen, X., et al. (2024). Effects of total coumarins from Pileostegia tomentella on exosomal miRNA expression and angiogenesis in colorectal cancer cells. Pharmaceutical Biology, 62(1), 153\u2013161.","journal-title":"Pharmaceutical Biology"},{"key":"1608_CR26","doi-asserted-by":"crossref","unstructured":"Ying, L., Kun, W., Li, L., Zhang, J., Liu, H., & Chen, Y. et al. (2023). Total coumarins of Pileostegia tomentella induces cell death in SCLC by reprogramming metabolic patterns, possibly through attenuating \u03b2-catenin\/AMPK\/SIRT1. Chinese Medicine, 18(1).","DOI":"10.1186\/s13020-022-00703-7"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-026-01608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-026-01608-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-026-01608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:37:46Z","timestamp":1792586266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-026-01608-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":26,"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1007\/s12033-026-01608-8","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing financial, professional, or personal interests that could have influenced the work reported in this study.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We (all authors) hereby confirm the following: Review and Authorization: This manuscript has been reviewed and its content and publication have been unanimously approved by all listed authors. Completeness of Authorship: All individuals who have made substantive contributions to this research and meet the authorship criteria have been included in the author list, with no omissions. Confirmation of Order: The order of authors listed in the manuscript has been agreed upon and approved by all authors. All authors hereby declare their consent for the submission and publication of this manuscript.","order":2,"name":"Ethics","label":"Publication Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}